Semi-Annual Consolidated Statement Of Income

Carna Biosciences, Inc. - Filing #7722864

Concept 2018-01-01 to
2018-06-30
2018-01-01 to
2018-06-30
2018-01-01 to
2018-06-30
2017-01-01 to
2017-06-30
2017-01-01 to
2017-06-30
2017-01-01 to
2017-06-30
Semi-annual consolidated statement of income
Statement of income
Net sales
349,114,000 JPY
50,000,000 JPY
399,114,000 JPY
326,799,000 JPY
326,799,000 JPY
JPY
Cost of sales
110,275,000 JPY
112,600,000 JPY
Ordinary profit (loss)
-443,148,000 JPY
-297,318,000 JPY
Gross profit (loss)
288,839,000 JPY
214,198,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
725,534,000 JPY
506,042,000 JPY
Extraordinary losses
44,615,000 JPY
17,649,000 JPY
Profit (loss) before income taxes
-487,764,000 JPY
-314,968,000 JPY
Operating profit (loss)
78,668,000 JPY
-515,363,000 JPY
-436,694,000 JPY
70,176,000 JPY
-291,843,000 JPY
-362,020,000 JPY
Income taxes - current
2,001,000 JPY
1,264,000 JPY
Non-operating income
Interest income
8,000 JPY
21,000 JPY
Dividend income
182,000 JPY
177,000 JPY
Non-operating income
674,000 JPY
6,055,000 JPY
Income taxes - deferred
-83,000 JPY
-90,000 JPY
Non-operating expenses
Interest expenses
5,611,000 JPY
3,540,000 JPY
Non-operating expenses
7,128,000 JPY
11,530,000 JPY
Income taxes
1,917,000 JPY
1,173,000 JPY
Profit (loss)
-489,682,000 JPY
-316,142,000 JPY
Extraordinary losses
Impairment losses
44,615,000 JPY
17,649,000 JPY
Profit (loss) attributable to owners of parent
-489,682,000 JPY
-316,142,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-497,000 JPY
72,000 JPY
Foreign currency translation adjustment
-967,000 JPY
-2,159,000 JPY
Other comprehensive income
-1,464,000 JPY
-2,087,000 JPY
Comprehensive income
-491,147,000 JPY
-318,229,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-491,147,000 JPY
-318,229,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.